The Wendy's Company (WEN) Stock Forecast
Data as of May 3, 2026Consumer Cyclical · Current price $6.74 (-3.09%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 17, 2026 | Jake Bartlett | Truist Financial | $10.00 | +48.4% |
| Feb 16, 2026 | Chris O'Cull | Stifel Nicolaus | $8.00 | +18.7% |
| Feb 16, 2026 | Brian Harbour | Morgan Stanley | $7.00 | +3.9% |
| Feb 5, 2026 | Chris O'Cull | Stifel Nicolaus | $9.00 | +33.5% |
| Jan 9, 2026 | Nick Setyan | Mizuho Securities | $7.00 | +3.9% |
| Dec 22, 2025 | Logan Reich | RBC Capital | $8.50 | +26.1% |
| Dec 17, 2025 | Christine Cho | Goldman Sachs | $8.00 | +18.7% |
| Oct 22, 2025 | Jeffrey Bernstein | Bernstein | $9.00 | +33.5% |
| Oct 14, 2025 | Jake Bartlett | Truist Financial | $12.00 | +78.0% |
| Aug 15, 2025 | Chris O'Cull | Stifel Nicolaus | $12.00 | +78.0% |
| Aug 11, 2025 | Jake Bartlett | Truist Financial | $13.00 | +92.9% |
| Aug 8, 2025 | Brian Mullan | Piper Sandler | $13.00 | +92.9% |
| Jul 14, 2025 | Brian Harbour | Morgan Stanley | $11.00 | +63.2% |
| May 6, 2025 | Andrew Strelzik | BMO Capital | $15.00 | +122.6% |
| May 5, 2025 | Jeffrey Bernstein | Bernstein | $13.00 | +92.9% |
| Apr 15, 2025 | Chris O'Cull | Stifel Nicolaus | $14.00 | +107.7% |
| Jan 10, 2025 | Chris O'Cull | Stifel Nicolaus | $17.00 | +152.2% |
| Nov 1, 2024 | David Palmer | Evercore ISI | $20.00 | +196.7% |
| Oct 7, 2024 | Jon Tower | Citigroup | $18.75 | +178.2% |
| Aug 2, 2024 | Chris O'Cull | Stifel Nicolaus | $19.00 | +181.9% |
Top Analysts Covering WEN
WEN vs Sector & Market
| Metric | WEN | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.19 | 2.52 | 2.41 |
| Analyst Count | 21 | 13 | 18 |
| Target Upside | +14.7% | +417.5% | +14.9% |
| P/E Ratio | 7.93 | 11.27 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $2.16B | $2.20B | $2.31B | 16 |
| 2027-03-28 | $511M | $524M | $552M | 6 |
| 2027-06-28 | $561M | $575M | $606M | 6 |
| 2027-09-28 | $553M | $567M | $597M | 6 |
| 2027-12-28 | $549M | $563M | $593M | 6 |
| 2028-03-28 | $525M | $538M | $567M | 5 |
| 2028-06-28 | $579M | $594M | $626M | 5 |
| 2028-09-28 | $575M | $589M | $621M | 5 |
| 2028-12-28 | $567M | $582M | $613M | 5 |
| 2029-12-28 | $2.27B | $2.34B | $2.44B | 8 |
| 2030-12-28 | $2.30B | $2.37B | $2.47B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $0.55 | $0.58 | $0.60 | 16 |
| 2027-03-28 | $0.11 | $0.11 | $0.12 | 7 |
| 2027-06-28 | $0.21 | $0.21 | $0.23 | 7 |
| 2027-09-28 | $0.18 | $0.19 | $0.20 | 7 |
| 2027-12-28 | $0.14 | $0.15 | $0.16 | 11 |
| 2028-03-28 | $0.12 | $0.12 | $0.13 | 8 |
| 2028-06-28 | $0.23 | $0.23 | $0.25 | 8 |
| 2028-09-28 | $0.19 | $0.20 | $0.21 | 8 |
| 2028-12-28 | $0.16 | $0.16 | $0.17 | 12 |
| 2029-12-28 | $0.89 | $0.93 | $0.98 | 1 |
| 2030-12-28 | $0.90 | $0.93 | $0.98 | 1 |
Frequently Asked Questions
What is the analyst consensus for WEN?
The consensus among 21 analysts covering The Wendy's Company (WEN) is Hold with an average price target of $8.15.
What is the highest price target for WEN?
The highest price target for WEN is $31.00, set by Alton Stump at Loop Capital Markets on 2021-10-15.
What is the lowest price target for WEN?
The lowest price target for WEN is $7.00, set by Nick Setyan at Mizuho Securities on 2026-01-09.
How many analysts cover WEN?
21 analysts have issued ratings for The Wendy's Company in the past 12 months.
Is WEN a buy or sell right now?
Based on 21 analyst ratings, WEN has a consensus rating of Hold (3.19/5) with a +14.7% upside to the consensus target of $8.15.
What are the earnings estimates for WEN?
Analysts estimate WEN will report EPS of $0.58 for the period ending 2026-12-28, with revenue estimated at $2.20B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.